LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 33.80 | 21.74 | 12 | 2381 | 0.0050 | -0.0840 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 33.80 | 21.74 | 1870 | 2381 | 0.7852 | 0.9299 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 35.77 | 21.74 | 52 | 2602 | 0.0200 | 0.1347 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 35.77 | 21.74 | 1986 | 2602 | 0.7630 | 0.9232 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 35.77 | 21.74 | 10 | 2602 | 0.0038 | -0.1064 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 35.77 | 21.74 | 2083 | 2602 | 0.8003 | 0.9365 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.74 | 21.74 | 77 | 2828 | 0.0272 | 0.1973 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.74 | 21.74 | 2130 | 2828 | 0.7531 | 0.9209 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.74 | 21.74 | 13 | 2828 | 0.0046 | -0.0706 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 37.74 | 21.74 | 2162 | 2828 | 0.7644 | 0.9249 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.71 | 21.74 | 103 | 3084 | 0.0334 | 0.2431 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.71 | 21.74 | 2333 | 3084 | 0.7565 | 0.9234 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.71 | 21.74 | 14 | 3084 | 0.0045 | -0.0597 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 39.71 | 21.74 | 2378 | 3084 | 0.7710 | 0.9286 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.68 | 21.74 | 143 | 3418 | 0.0418 | 0.2945 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.68 | 21.74 | 2519 | 3418 | 0.7368 | 0.9180 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.68 | 21.74 | 55 | 3418 | 0.0161 | 0.1357 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 41.68 | 21.74 | 2608 | 3418 | 0.7628 | 0.9272 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.65 | 21.74 | 153 | 3754 | 0.0408 | 0.3003 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.65 | 21.74 | 2737 | 3754 | 0.7291 | 0.9167 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.65 | 21.74 | 54 | 3754 | 0.0144 | 0.1302 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 43.65 | 21.74 | 2844 | 3754 | 0.7576 | 0.9267 | MN20160310_N01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.62 | 21.74 | 199 | 4150 | 0.0479 | 0.3394 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.62 | 21.74 | 3010 | 4150 | 0.7252 | 0.9169 | MN20160310_N01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 45.62 | 21.74 | 52 | 4150 | 0.0125 | 0.1220 | MN20160310_N01 | K13 |